These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38271328)
1. Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines. Yamanaka T; Castro MC; Ferrer JP; Solon JA; Cox SE; Laurence YV; Vassall A PLoS One; 2024; 19(1):e0297342. PubMed ID: 38271328 [TBL] [Abstract][Full Text] [Related]
2. Comparing disease specific catastrophic cost estimates using longitudinal and cross-sectional designs: The example of tuberculosis. Yamanaka T; Castro MC; Ferrer JP; Cox SE; Laurence YV; Vassall A Soc Sci Med; 2024 Mar; 344():116631. PubMed ID: 38308959 [TBL] [Abstract][Full Text] [Related]
3. Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines. Florentino JL; Arao RML; Garfin AMC; Gaviola DMG; Tan CR; Yadav RP; Hiatt T; Morishita F; Siroka A; Yamanaka T; Nishikiori N PLoS One; 2022; 17(2):e0264689. PubMed ID: 35226705 [TBL] [Abstract][Full Text] [Related]
4. Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey. Youngkong S; Kamolwat P; Wongrot P; Thavorncharoensap M; Chaikledkaew U; Nateniyom S; Pungrassami P; Praditsitthikorn N; Mahasirimongkol S; Jittikoon J; Nishikiori N; Baena IG; Yamanaka T Sci Rep; 2024 May; 14(1):11205. PubMed ID: 38755216 [TBL] [Abstract][Full Text] [Related]
5. The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021. Noia Maciel EL; Negri LDSA; Guidoni LM; Fregona GC; Johansen FDC; Sanchez MN; Moreira ADSR; Diaz-Quijano FA; Tonini M; Zandonade E; Ershova J; Nguhiu P; Baena IG PLoS One; 2023; 18(12):e0287961. PubMed ID: 38091306 [TBL] [Abstract][Full Text] [Related]
6. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey. Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392 [TBL] [Abstract][Full Text] [Related]
7. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. Oliveira Hashiguchi L; Cox SE; Edwards T; Castro MC; Khan M; Liverani M BMC Health Serv Res; 2023 Sep; 23(1):1027. PubMed ID: 37749519 [TBL] [Abstract][Full Text] [Related]
8. Patient-cost survey for tuberculosis in the context of patient-pathway modelling. Tomeny EM; Mendoza VL; Marcelo DB; Barrameda AJD; Langley I; Abong JM; Dalay VB; Yu CY; Squire SB Int J Tuberc Lung Dis; 2020 Apr; 24(4):420-427. PubMed ID: 32317067 [No Abstract] [Full Text] [Related]
9. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage. Fuady A; Houweling TAJ; Mansyur M; Richardus JH Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589 [TBL] [Abstract][Full Text] [Related]
10. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study. Pham TAM; Forse R; Codlin AJ; Phan THY; Nguyen TT; Nguyen N; Vo LNQ; Dat PT; Minh HDT; Nguyen LH; Nguyen HB; Nguyen NV; Bodfish M; Lönnroth K; Wingfield T; Annerstedt KS BMC Public Health; 2023 Dec; 23(1):2372. PubMed ID: 38042797 [TBL] [Abstract][Full Text] [Related]
11. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China. Yang T; Chen T; Che Y; Chen Q; Bo D BMC Public Health; 2020 Jun; 20(1):1009. PubMed ID: 32586305 [TBL] [Abstract][Full Text] [Related]
12. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status. Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777 [TBL] [Abstract][Full Text] [Related]
13. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households. Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063 [TBL] [Abstract][Full Text] [Related]
14. Tuberculosis patients face high treatment support costs in Colombia, 2021. Cruz Martínez OA; García I; Puerto GM; Alvis-Zakzuk NJ; López MP; Moreno Cubides JC; Sánchez Salazar ÁM; Trujillo Trujillo J; Castro-Osorio CM; Vanessa Rubio V; Castañeda-Orjuela C; Montoro E; Nguhiu P; García Baena I PLoS One; 2024; 19(4):e0296250. PubMed ID: 38635755 [TBL] [Abstract][Full Text] [Related]
15. Inequity in catastrophic costs among tuberculosis-affected households in China. Xu CH; Jeyashree K; Shewade HD; Xia YY; Wang LX; Liu Y; Zhang H; Wang L Infect Dis Poverty; 2019 Jun; 8(1):46. PubMed ID: 31215476 [TBL] [Abstract][Full Text] [Related]
16. Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies. Ghazy RM; Sallam M; Ashmawy R; Elzorkany AM; Reyad OA; Hamdy NA; Khedr H; Mosallam RA Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36768005 [TBL] [Abstract][Full Text] [Related]
17. The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal. Gurung SC; Dixit K; Rai B; Caws M; Paudel PR; Dhital R; Acharya S; Budhathoki G; Malla D; Levy JW; van Rest J; Lönnroth K; Viney K; Ramsay A; Wingfield T; Basnyat B; Thapa A; Squire B; Wang D; Mishra G; Shah K; Shrestha A; de Siqueira-Filha NT Infect Dis Poverty; 2019 Dec; 8(1):99. PubMed ID: 31791412 [TBL] [Abstract][Full Text] [Related]
18. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. Wingfield T; Boccia D; Tovar M; Gavino A; Zevallos K; Montoya R; Lönnroth K; Evans CA PLoS Med; 2014 Jul; 11(7):e1001675. PubMed ID: 25025331 [TBL] [Abstract][Full Text] [Related]
19. Measuring catastrophic costs due to tuberculosis in Viet Nam. Nhung NV; Hoa NB; Anh NT; Anh LTN; Siroka A; Lönnroth K; Garcia Baena I Int J Tuberc Lung Dis; 2018 Sep; 22(9):983-990. PubMed ID: 30092862 [TBL] [Abstract][Full Text] [Related]
20. Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in Africa. Evans D; van Rensburg C; Govathson C; Ivanova O; Rieß F; Siroka A; Sillah AK; Ntinginya NE; Jani I; Sathar F; Rosen S; Sanne I; Rachow A; Lönnroth K Glob Health Action; 2021 Jan; 14(1):1865625. PubMed ID: 33491593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]